OPR - Delayed Quote • USD PRCT Oct 2024 55.000 call (PRCT241018C00055000) Follow 8.60 0.00 (0.00%) At close: April 16 at 2:58 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for PRCT241018C00055000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PRCT PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024 Masimo (MASI) Soars 3.3%: Is Further Upside Left in the Stock? PROCEPT BioRobotics Corp (PRCT) President and CEO Reza Zadno Sells Company Shares EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics Corp (PRCT) Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT) PROCEPT BioRobotics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags Q4 2023 Procept Biorobotics Corp Earnings Call PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2023 Earnings Call Transcript PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results Earnings Preview: Integra LifeSciences (IART) Q4 Earnings Expected to Decline
